Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

41results about How to "Good treatment effect" patented technology

Traditional Chinese medicine composition for treating alcoholic liver

InactiveCN103301412AFully functionalGood treatment effectDigestive systemPlant ingredientsBiologyCrataegus pinnatifida
The invention discloses a traditional Chinese medicine composition for treating an alcoholic liver, and relates to the technical field of the traditional Chinese medicine. Aiming at the defects that overall effective treatment is in shortage on an alcoholic liver disease at present while recurrence is easily generated in chemical treatment, and the curative effect cannot last in the prior art, the invention provides the traditional Chinese medicine composition for treating the alcoholic liver. The traditional Chinese medicine composition is prepared from the following materials in parts by weight: 10 parts of rhizoma alismatis, 15 parts of peach kernel, 6 parts of capillary artemisia,10 parts of pseudo-ginseng, 10 parts of ligusticum wallichii, 6 parts of root of red-rooted salvia, 20 parts of fructus aurantii, 20 parts of hawthorn, 10 parts of radix bupleuri, 12 parts of radix curcumae, 15 parts of scutellaria baicalensis, 30 parts of tribulusterrestris, 6 parts of polygonum cuspidatum and 10 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention has a good treatment effect in the aspect of treatment of the alcoholic liver disease, and has significant clinical popularization value.
Owner:崔新明

siRNA molecule composition, and applications thereof in treatment of hypertrophic scars

InactiveCN103642800APromoting apoptosis of hypertrophic scar fibroblastsGood treatment effectGenetic material ingredientsDermatological disorderTreatment effectFibrocyte
The invention relates to a siRNA molecule composition, and applications thereof in treatment of hypertrophic scars. The siRNA molecule composition comprises siRNA molecules, whose nucleotide sequence comprises a) 5'-ccccggaggugauuuccaucuacaa-3', and 5'-uuguagauggaaaucaccuccgggg-3'; and siRNA molecules, whose nucleotide sequence comprises b) 5'-gucuuuggucuggugccuggucuga-3', and 5'-ucagaccaggcaccagaccaaagac-3'. The siRNA molecule composition is capable of promoting apoptosis of hypertrophic scar fibroblast in vitro, and possesses excellent therapeutic effect on hypertrophic scars of animal models.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Aspirin pharmaceutical composition and application thereof in biological medicine

InactiveCN105753928AHas therapeutic effectGood treatment effectOrganic active ingredientsSteroidsAspirinNatural product
The invention discloses an aspirin pharmaceutical composition and application thereof in biological medicine.The aspirin pharmaceutical composition is prepared from aspirin and a natural product compound (I) of a novel structure.The composition of aspirin and the compound (I) can remarkably reduce lung injury caused by septicopyemia, has a better effect than that achieved when aspirin or the compound (I) acts alone, can be developed into medicine for treating acute lung injury, and has the outstanding substantive features and achieves a remarkable progress compared with the prior art.
Owner:陈昊

Traditional Chinese medicine used for treating haemorrhoids

InactiveCN106063889AGood treatment effectNo side effectsCardiovascular disorderConiferophyta medical ingredientsAgrimonia pilosaAloe ferox
The invention discloses a traditional Chinese medicine used for treating haemorrhoids. The traditional Chinese medicine comprises an external-use traditional Chinese medicine combination and an orally-taken traditional Chinese medicine combination, wherein the external-use traditional Chinese medicine combination is prepared from the following traditional Chinese medicines in parts by weight: 20-35 parts of musk, 20-35 parts of calculus bovis, 20-35 parts of flos daturae, 20-35 parts of aloes, 18-25 parts of calamine, 18-25 parts of golden cypress, 18-25 parts of borneo camphor, 18-25 parts of sophora flavescens, 18-25 parts of safflower, 18-25 parts of borax and 18-25 parts of honeysuckles; the orally-taken traditional Chinese medicine combination is prepared from the following traditional Chinese medicines in parts by weight: 12-18 parts of sanguisorba officinalis, 12-18 parts of flos sophorae, 12-18 parts of honeysuckles, 12-18 parts of cinnamon, 12-18 parts of poria cocos, 12-18 parts of agrimonia pilosa ledeb, 12-18 parts of cacumen biotae, 8-15 parts of safflower, 8-15 parts of caulis akebiae, 8-15 parts of radix asteris, 8-15 parts of calculus bovis, 8-15 parts of liquorice, 8-15 parts of polygonum multiflorum, 8-15 parts of chinarue, 8-15 parts of divaricate saposhnikovia roots, 8-15 parts of radix sophorae flavescentis, 4-7 parts of rubia cordifolia, 4-7 parts of lalang grass rhizome, 4-7 parts of eclipta alba, 4-7 parts of root barks of white mulberry and 4-7 parts of Chinese angelica. The traditional Chinese medicine used for treating haemorrhoids is short in cure time, is free of toxic or side effect, and has a cure rate of 87% or above without an operation.
Owner:蒋安美

Degradable drug eluting stent and preparation method thereof

The invention provides a preparation method of a degradable drug eluting stent. The preparation method comprises the following steps: A) heating a degradable macromolecular polymer pipe to deformation temperature, and then expanding the degradable macromolecular polymer pipe in the radial direction and / or axial direction of the degradable macromolecular polymer pipe, so that an expanded pipe is obtained, wherein the wall thickness of the expanded pipe is no less than 80mu m, and the radial expansion rate of the degradable macromolecular polymer pipe is 400-800%; B) cutting the expanded pipe, so that a bare stent is obtained; and C) carrying out surface treatment on the bare stent, and then coating with a degradable drug coating, so that the degradable drug eluting stent is obtained.
Owner:SHANGHAI MAIQUAN MEDICAL INSTR CO LTD

Preparation method of medicinal and edible dual-purpose blood-sugar-reducing nutritious healthcare tea

The invention relates to a preparation method of medicinal and edible dual-purpose blood-sugar-reducing nutritious healthcare tea which can treat diabetes mellitus, especially diabetes mellitus type 2. The medicinal and edible dual-purpose blood-sugar-reducing nutritious healthcare tea is made of Tiegun Chinese yams, fragrant solomonseal rhizomes, cornus pulp, Chinese magnolia vine fruits, inula flowers, rehmanniae and licorice roots in a mixing way. The preparation method comprises the steps of: cleaning and peeling the Tiegun Chinese yams, soaking in water for color fixation for 30 minutes, putting the Tiegun Chinese yams, the fragrant solomonseal rhizomes and the cornus pulp in infrared drying equipment for sterilizing and drying 330 minutes at 70 DEG C, grinding and crushing the raw materials to be 200-mesh and mixing in proportion. The medicinal and edible dual-purpose blood-sugar-reducing nutritious healthcare tea is purely natural, does not have toxic and side effects, has an excellent and quick treatment effect, not only can alleviate the symptoms, but also can effect a permanent cure, is small in cost, has primary colour and taste, can be drunk for medicinal and edible purposes, is integrated with curative and healthcare effects, is small in volume and convenient to carry and can be preserved for a long time.
Owner:张康

Medicinal composition for treating gout

InactiveCN108904652ALittle side effectsLow cost of treatmentSkeletal disorderFungi medical ingredientsCarthamusHerb
The invention relates to a medicinal composition for treating gout. The medicinal composition is characterized by being prepared from the following Chinese herbs: 15g of dandelion flower, 10g of herbaviolae, 12g of flos lonicerae, 10g of herba patriniae, 10g of peach kernel (fried), 10g of flos carthami, 12g of radix paeoniae rubra, 10g of rhizoma Chuangxiong, 10g of radix angelicae sinensis, 10gof semen phaseoli, 10g of rhizoma alismatis (salty), 15g of semen plantaginis, 15g of poria peel, 12g of umbellate pore fungus, 10g of radix aucklandiae, 10g of pericarpium citri reticulatae viride,10g of pericarpium citri reticulatae, 12g of cortex magnoliae officinalis, and 6g of licorice roots, the Chinese herbs are mixed according to a given ratio and crushed into fine powder of 80 to 100 mesh, then the powder is made into pills in a weight of 10g, two pills are taken one time, three times for one day, seven days form one treatment course, and a good effect can be achieved after the pills are taken for two treatment courses.
Owner:杨塬

Composition for treating brown spot of kiwifruits

InactiveCN107646902AGood treatment effectDisease controlBiocideFungicidesActinidiaBreynia
The invention relates to the field of pesticides, in particular to a composition for treating brown spot of kiwifruits. The composition comprises, by weight, 20-30 parts of spica prunellae, 6-9 partsof herba schizonepetae, 10-20 parts of herba moslae, 8-12 parts of catechu, 10-20 parts of actinidia chinensis planch, 6-9 parts of herba polygoni chinensis, 8-12 parts of leaves of eucalyptus robusta, 10-20 parts of herba inulae, 15-25 parts of shrubby breynia, 2-4 parts of fructus viticis, 12-18 parts of elatostema stewardii, 8-12 parts of herba spirodelae and 8-12 parts of compound bacteria. The composition has the advantages that obvious effects of treating the brown spot of the kiwifruits can be realized by the treatment composition, the average total efficiency rate is higher than 96%, the average total cure rate is higher than 93%, kiwifruit brown spot morbidity conditions can be effectively controlled, the shortcomings due to the traditional medicine treatment can be overcome by the aid of the composition, and medicine residues in the kiwifruits can be reduced.
Owner:ZIYUN MIAO & BUYI AUTONOMOUS COUNTY HUAPENG AGRI TECH DEV CO LTD

Suspending agent containing methoxycarbamate and cyazofamid and application thereof

PendingCN114642210AGood treatment effectRaw materials are easy to getBiocideFungicidesCarbamatePhytotoxicity
The invention relates to the technical field of pesticides, in particular to a suspending agent containing methoxycarbamate and cyazofamid and application of the suspending agent. The bactericidal composition comprises the following raw materials: active components, wherein the active components comprise methoxycarbamate and cyazofamid; the methoxyl carbamate is pyraclostrobin, and the methoxyl carbamate is pyraclostrobin. The suspending agent provided by the invention has the following advantages: (1) the suspending agent has a remarkable treatment effect on grape downy mildew, and provides a powerful guarantee for high-yield and high-quality cultivation of grapes; (2) the suspending agent has the advantages of easily available raw materials, simple process and strong practical operation feasibility, and can be widely applied to the field of prevention and treatment of downy mildew; (3) the suspending agent has excellent stability while having a high downy mildew prevention effect, can be stored for a long time at high temperature, and is low in decomposition rate and free of layering and color changing phenomena; and (4) the suspending agent is high in safety, does not cause phytotoxicity to crops, accords with industrial regulations in toxicological tests, and has a wide application prospect.
Owner:SHANDONG TONGFANG BIOTECHNOLOGY CO LTD

Traditional Chinese medicine composition for treating allergic rhinitis and chronic rhinitis and preparation method thereof

PendingCN114404502AAvoid side effectsGood treatment effectImmunological disordersPlant ingredientsACTINIDIA CHINENSIS ROOTACTINIDIA POLYGAMA FRUIT
The invention discloses a traditional Chinese medicine composition for treating allergic rhinitis and chronic rhinitis. Belongs to the technical field of external medicines for rhinitis. The external medicine comprises the following components in parts by weight: fresh actinidia chinensis root, fresh sculellaria barbata, dried sculellaria barbata, solanum lyratum, asarum, flos magnolia, selaginella doederleinii, subprostrate sophora, oldenlandia diffusa, Chinese lobelia, dayflower, cocklebur fruit, rhizoma atractylodis, radix angelicae, centipeda minima, houttuynia cordata, fructus piperis longi, liquorice, schizonepeta, mint, fermented soybean, divaricate saposhnikovia root, cimicifugae foetidae, honeysuckle, dandelion and herba violae. The invention discloses a traditional Chinese medicine composition for treating allergic rhinitis and chronic rhinitis and a preparation method of the traditional Chinese medicine composition for treating allergic rhinitis and chronic rhinitis, the traditional Chinese medicine composition can treat allergic rhinitis and chronic rhinitis at the same time and relieve the allergic rhinitis and chronic rhinitis at the same time, the treatment effect is remarkable, no side effect exists, and the curative effect can be kept for 3-5 years.
Owner:向延友

Application of GOLT1B inhibitor in preparation of medicine for treating colorectal cancer

The invention relates to the field of medical biology, in particular to application of a GOLT1B inhibitor in preparation of a medicine for treating colorectal cancer. Scratch and invasion experimentsshow that the migration and invasion performance of colorectal cancer cells treated by the GOLT1B inhibitor are remarkably reduced. Therefore, the GOLT1B inhibitor provided by the invention can inhibit metastasis of the colorectal cancer to improve the treatment effect of the colorectal cancer.
Owner:THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Traditional Chinese medicine preparation for osteoporosis, osteonecrosis, bone generation and blood circulation promotion and preparation method thereof

InactiveCN111249367APromote proliferationObvious effectHeavy metal active ingredientsSkeletal disorderPremna fulvaOsteoporotic bone
The invention discloses a traditional Chinese medicine preparation for osteoporosis, osteonecrosis, bone generation and blood circulation promotion. The traditional Chinese medicine preparation is prepared from premna fulva Craib, sarcandra twigs and leaves, natural copper, red sage roots, corydalis tubers, twotoothed achyranthes roots and eucommia bark. The invention also provides a preparation method of the traditional Chinese medicine preparation. According to the principle of combining the traditional Chinese medicine theory and the western medicine theory, the traditional Chinese medicinepreparation provided by the invention is scientifically proportioned, and the traditional Chinese medicines are matched with each other to offset weakness, so that traditional Chinese medicine preparation has the effects of promoting blood circulation and removing blood stasis, dredging collaterals and setting bones, relieving swelling and pain, and strengthening tendons and bones, and has obvious effects on treating fracture, osteoporosis and osteonecrosis. Pharmacodynamic and toxicological tests show that the traditional Chinese medicine preparation has obvious effects, has no toxic or sideeffects, and overcomes the defects that western medicines can damage liver and kidney functions and the like after being taken for a long time. The traditional Chinese medicine preparation prepared by using a folk secret prescription of the Zhuang nationality can be prepared into various dosage forms, is convenient and safe to carry and take, and reduces or avoids danger, injury and pain caused by intravenous drip and intramuscular injection treatment. The traditional Chinese medicine preparation has advantages of short treatment course, quick response and wide application range, and has a wide application prospect.
Owner:HUANBAO PHARMA

Traditional Chinese medicine preparation for treating high blood pressure

InactiveCN112138050AImprove vasoconstriction functionImprove abnormalities such as vasoconstriction functionMetabolism disorderAlgae medical ingredientsSide effectTherapeutic effect
The invention discloses a traditional Chinese medicine preparation for treating high blood pressure. The traditional Chinese medicine preparation is characterized by being prepared from the followingtraditional Chinese medicine raw materials in parts by weight: 50-250 parts of cassia seeds, 50-300 parts of hawthorn and 200-600 parts of seaweed. The traditional Chinese medicine preparation is mainly used for reducing blood pressure, improving abnormalities of hemodynamics, hemorheology, vasoconstriction and the like of patients suffering from high blood pressure, adjusting fibrinolytic systemfunctions and platelet functions in blood and correcting metabolic disorders of various substances, has the effects of reducing blood pressure, reducing blood fat and resisting blood coagulation, andhas a remarkable prevention and treatment effect on high blood pressure. The traditional Chinese medicine preparation is simple in formula, low in cost, good in effect and capable of effectively preventing side effects caused by use of western medicines.
Owner:CHONGQING PEIDU PHARMA

Application of TROAP in preparation of renal cell carcinoma prognosis product and therapeutic drug

ActiveCN113699233APromote proliferationPromote migrationMicrobiological testing/measurementUrinary disorderIndividualized treatmentApoptosis
The invention belongs to the field of biological medicine, and relates to application of TROAP in preparation of renal cell carcinoma prognosis products and therapeutic drugs. Experiments find and prove that the TROAP gene can promote proliferation, migration and invasion of renal carcinoma cells and inhibit apoptosis at the same time, and is a very important marker for renal carcinoma progression. On the basis, the TROAP gene is used as a screened molecular marker, the prognosis condition of a renal cell carcinoma patient is judged by detecting the expression level of the TROAP, clinical treatment is guided through a prognosis model, and the application has important practical application value for evaluating the prognosis of the patient and guiding the individualized treatment of the patient. Meanwhile, the ROAP gene serves as a targeted drug development action target, a new inhibitor and a new drug development target are provided for the renal clear cell carcinoma, especially metastatic clear cell carcinoma, and the early warning capacity and the subsequent treatment effect on the patients of the type are improved.
Owner:CHANGZHOU NO 2 PEOPLES HOSPITAL +1

Traditional Chinese medicinal feed for poultry

InactiveCN104431331AGood therapeutic effectGood treatment effectAnimal feeding stuffAstragalus mongholicusAstragalus Root
The invention discloses a traditional Chinese medicinal feed for poultry. The traditional Chinese medicinal feed for the poultry is prepared from the following raw materials in percentage by weight: 60-80 percent of grain and 20-40 percent of traditional Chinese medicine, wherein the grains are on ore more of corns, bean cakes and sorghums; the traditional Chinese medicines are prepared from the following medicinal raw materials in percentage by weight: 2-25 percent of ginseng, 1-20 percent of glossy privet fruit, 1-20 percent of feather cockscomb seed, 1-20 percent of tortoise plastron, 2-15 percent of oyster, 1-20 percent of fruit of Chinese wolfberry, 1-15 percent of astragalus root and 1-15 percent of polygonum multiflorum. The poultry fed by the traditional Chinese medicinal feed which is prepared by the formula and egg products of the poultry have the characteristics of high nutrition, low cholesterol, nutrition equilibrium and homology of medicines and foods. With the adoption of the traditional Chinese medicinal feed, for an organism eating the eggs, the eggs have the functions of resisting ageing and improving the immunity, also have very outstanding treatment function to patients with diabetes mellitus and cardio-cerebrovascular disease, have good curative effect to patients with general deficiency of qi, short physical strength, kidney deficiency, face without brightness, advanced pulmonary tuberculosis, insomnia and dreaminess and are also good health products for common people.
Owner:TIANJIN WANDA JIAHE FEED

Pharmaceutical composition containing sinogastromyzon extract and preparation method thereof

The invention discloses a pharmaceutical composition containing sinogastromyzon extract and a preparation method thereof. The pharmaceutical composition is prepared from the following components in parts by weight: 10-20 parts of the sinogastromyzon extract, 10-17 parts of gastrodin, 3-7 parts of sodium morrhuate, 6-10 parts of fructus gardeniae, 2-5 parts of calcium disodium versenate, 4-8 partsof tartary buckwheat flavonoids and 2-6 parts of etamsylate. The pharmaceutical composition is prepared by compounding the sinogastromyzon extract, the gastrodin, the sodium morrhuate, the fructus gardeniae, the calcium disodium versenate, the tartary buckwheat flavonoids and the etamsylate and has a good radical treatment effect on whelks, acne marks are not left after being cured, the treatmenteffect is good, the total effective rate reaches 99%, and the pharmaceutical composition is worthy of popularization.
Owner:JIANGSU AGRI ANIMAL HUSBANDRY VOCATIONAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products